Two-in-one drug combining Herceptin with chemotherapy keeps women's breast cancers at bay

Guiding chemotherapy to a tumour by attaching it to the antibody-based target drug Herceptin (trastuzumab) is effective at treating women with breast cancer who have no other treatment options, a new clinical trial shows.

* This article was originally published here